跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
CCN family member 1 deregulates cholesterol metabolism and aggravates atherosclerosis
Jin Feng Zhao
, Hsiang Ying Chen
, Jeng Wei
,
Shr Jeng Jim Leu
*
, Tzong Shyuan Lee
*
此作品的通信作者
醫學生物技術暨檢驗學系
研究成果
:
Article
›
同行評審
21
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「CCN family member 1 deregulates cholesterol metabolism and aggravates atherosclerosis」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Cholesterol Metabolism
100%
Low-Density Lipoprotein
100%
Macrophage
75%
Protein Expression
75%
Lipid Storage
75%
Apolipoprotein E Knockout Mouse
75%
Cytokine
50%
Liver X Receptor
50%
ATP-binding Cassette Transporter
50%
ABC Transporter
50%
ABCG1
50%
LDL Receptor
25%
Triglyceride
25%
Downregulation
25%
Gene Expression
25%
Hydrolase
25%
Western Blot
25%
Small Interfering RNA
25%
Neutralizing Antibody
25%
Reverse Transcription Polymerase Chain Reaction
25%
Apolipoprotein E
25%
Lipid Liver Level
25%
Hyperlipidemia
25%
ABCA1
25%
Foam Cell
25%
ABCG8
25%
ABCG5
25%
Reverse Cholesterol Transport
25%
Artificial Intelligence
25%
High-Density Lipoprotein
25%
Apolipoprotein
25%
Immunology and Microbiology
Atherosclerosis
100%
Cholesterol Metabolism
100%
Low-Density Lipoprotein
100%
Macrophage
75%
Lipid Storage
75%
Protein Expression
75%
Apolipoprotein E Knockout Mouse
75%
Cytokine
50%
Downregulation
25%
Gene Expression
25%
Western Blot
25%
Neutralizing Antibody
25%
Reverse Transcription Polymerase Chain Reaction
25%
Extracellular Matrix
25%
Systemic Inflammation
25%
Foam Cell
25%
Lipid Liver Level
25%
Cholesterol Transport
25%
Artificial Intelligence
25%
High-Density Lipoprotein
25%
Apolipoprotein
25%
Apolipoprotein E
25%
Keyphrases
Family Members
100%
CCN Family
100%
Cholesterol Metabolism
100%
CCN1
100%
Oxidized Low-density Lipoprotein (ox-LDL)
36%
Cholesterol
27%
Protein Expression
27%
ATP-binding Cassette Transporter A1 (ABCA1)
27%
ApoE KO Mice
27%
Aorta
18%
Lipid Accumulation
18%
Liver X Receptor
18%
ABCG1
18%
Quantitative PCR
9%
Macrophages
9%
Overexpression
9%
Gene Expression
9%
Small Interfering RNA (siRNA)
9%
Liver
9%
Triglycerides
9%
High-density Lipoprotein Cholesterol (HDL-C)
9%
Western Blot Analysis
9%
Neutralizing Antibodies
9%
Extracellular Matrix
9%
Co-treatment
9%
Atherosclerotic Lesions
9%
In Vitro Model
9%
Hydrolases
9%
In Vivo Model
9%
Systemic Inflammation
9%
Atherosclerosis Progression
9%
Apolipoprotein A-I (ApoA-I)
9%
Cholesterol Efflux
9%
Macrophage Foam Cells
9%
Foamy Macrophages
9%
Assay Kit
9%
Apolipoprotein E-deficient
9%
Hepatic Lipid Accumulation
9%
ABCG8
9%
ABCG5
9%
LDL Receptor
9%
Reverse Cholesterol Transport
9%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
100%
Oxidized Low Density Lipoprotein
100%
Apolipoprotein E Knockout Mouse
75%
Cytokine
50%
Liver X Receptor
50%
Inflammation
25%
Low Density Lipoprotein Receptor
25%
Western Blot
25%
Hydrolase
25%
Small Interfering RNA
25%
Hyperlipidemia
25%
Effusion
25%
Neutralizing Antibody
25%
Triacylglycerol
25%
Apolipoprotein E
25%
High Density Lipoprotein
25%
ABC Transporter A1
25%
ABC Transporter
25%
Apolipoprotein
25%